Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): SARS-CoV-2 vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Vaccine
Partner/Sponsor/Collaborator: Flinders University
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership May 12, 2020
Details:
Proteona will use its ESCAPE™ technology to profile the immune response of patients receiving the vaccine. The technology will be used by Professor Petrovsky to characterize the clinical response to a new SARS-CoV-2 vaccine which is under investigation.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
